Blackbox JP
Upcoming event

Investor Day Japan Fall 2026

This event brings together the BioLabs Friends in Japan and the global BioLabs network to provide a platform for early- to mid-stage drug discovery startups to share their stories with investors and industry experts from Japan and around the world.

When
Tue, November 10, 2026 · 11:30 PM – Wed, November 11, 2026 · 4:00 AM
Where
Nihonbashi Life Science Building
City
tokyo
Investor Day Japan Fall 2026

iCONM in collaboration with BioLabs, Astellas Pharma Inc., LINK-J, and BioLabs Global (U.S.) will co-host Investor Day Japan 2026. Following the tremendous success of Investor Day Japan Spring 2026, held this past March, this event marks the second edition of the Investor Day Japan series. ▶ Read the Investor Day Japan Spring 2026 Event Report here

This event brings together the BioLabs Friends in Japan and the global BioLabs network to provide a platform for early- to mid-stage drug discovery startups to share their stories with investors and industry experts from Japan and around the world. Through this event, we aim to help participating startups seize new business opportunities and accelerate the growth of their drug discovery ventures. In addition, through networking with global VCs and investors, exclusive awards, and expert pitch coaching, we support participating startups in building global partnerships and accelerating their growth. Several other venture capital firms are expected to participate on-site. Finalists will have the opportunity not only to pitch to investors from Japan and abroad, but also to receive live feedback from experienced venture capitalists.

Event Schedule

Date:Nov 11, 2026 Venue: Nihonbashi Life Science Building 201, Tokyo Format: Startup Pitch Presentations: Hybrid Panel Discussion & Networking Reception: On-site only

Agenda

8:30 AM – 10:15 AM JST | HYBRID

Startup Pitch Presentations (5-minute Pitch + 5-minute Q&A)

Hear 8 biotech startups pitch to life science investors and industry experts from Japan and around the world, followed by live Q&A and feedback. Coffee and pastries will be provided!

10:30 AM – 11:15 AM JST | ON-SITE

Panel Discussion (45 minutes) What Makes a Japanese Biotech Globally Investable? Interactive discussion with global life science investors

What does it really take for a Japanese biotech to attract global investment? Join global life science investors for a candid, 45-minute interactive discussion exploring what they look for when evaluating biotech companies and what Japanese startups can do to position themselves for global investment (More details, including panelists, will be announced on this page in mid-October).

11:30 AM – 1:00 PM JST | ON-SITE

Networking Lunch

Continue the conversation over lunch and connect with startups, investors, pharma, and members of the broader life science ecosystem. Lunch will be provided!

Key Dates

Startup Applications: Aug 7 – Sep 24, 2026 (JST) — Closed Finalists Announced: Sep 30, 2026 (JST)

Audience Registration Opens: Oct 5, 2026 (JST) Pitch Seminar (Virtual): 8:00 AM – 9:00 AM, Oct 15, 2026 (JST) | 7:00 PM – 8:00 PM, Oct 14, 2026 (ET) Pitch Practice (Virtual): Oct 16 – Oct 30, 2026 (JST)

Investor Day: Nov 11, 2026 (JST)

Eligibility

Startup applications for 2026 are now closed. Thank you to everyone who applied.

– Research Area: Drug discovery and development related to therapeutic pharmaceuticals (all modalities are welcome) – Disease Area: Open to all disease areas. – Who Can Apply: Researchers or entrepreneurs aiming to found a startup in the above fields, as well as startups at the Seed to Series A fundraising stage.

For Finalists

Finalists will present in English on-site during Investor Day. Each startup will have a 5-minute pitch followed by a 5-minute Q&A. A virtual Pitch Seminar and Pitch Practice Sessions will also be provided ahead of Investor Day.

Find out more and register here.

Subscribe